Related Experiment Video
Updated: May 25, 2026
09:04
A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
New guaianolides from Artemisia anomala
Ze-Hua Hu1, Peng Zhang, De-Bin Huang
1Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China.
Journal of Asian Natural Products Research
|February 3, 2012
Summary
Two novel guaianolides, artemanomalides A and B, were identified from Artemisia anomala. Both compounds demonstrated significant inhibitory effects against the cyclooxygenase-2 (COX-2) enzyme.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Artemisia anomala S. Moore is a plant species known for its potential medicinal properties.
- Guaianolides are a class of sesquiterpene lactones with diverse biological activities.
Purpose of the Study:
- To isolate and characterize new guaianolides from Artemisia anomala.
- To evaluate the inhibitory potential of isolated compounds against the cyclooxygenase-2 (COX-2) enzyme.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation through extensive spectroscopic analyses (NMR, MS).
- In vitro enzymatic assay to determine COX-2 inhibitory activity.
Main Results:
- Two new guaianolides, artemanomalides A (1) and B (2), were successfully isolated and structurally characterized.
- Artemanomalide A exhibited an IC(50) value of 8.8 μM against COX-2.
- Artemanomalide B displayed potent COX-2 inhibition with an IC(50) value of 3.6 μM.
Conclusions:
- Artemisia anomala is a source of novel guaianolides with potential anti-inflammatory properties.
- Artemanomalides A and B represent promising leads for the development of COX-2 inhibitors.
